HRP20020513B1 - Substituted bisindolylmaleimides for the inhibition of cell proliferation - Google Patents

Substituted bisindolylmaleimides for the inhibition of cell proliferation

Info

Publication number
HRP20020513B1
HRP20020513B1 HR20020513A HRP20020513A HRP20020513B1 HR P20020513 B1 HRP20020513 B1 HR P20020513B1 HR 20020513 A HR20020513 A HR 20020513A HR P20020513 A HRP20020513 A HR P20020513A HR P20020513 B1 HRP20020513 B1 HR P20020513B1
Authority
HR
Croatia
Prior art keywords
inhibition
cell proliferation
bisindolylmaleimides
substituted
substituted bisindolylmaleimides
Prior art date
Application number
HR20020513A
Other languages
English (en)
Inventor
Fotouhi Nader
Emily
Allen
John
Federico Weber Giuseppe
Original Assignee
F. Hoffmann - La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann - La Roche Ag filed Critical F. Hoffmann - La Roche Ag
Publication of HRP20020513A2 publication Critical patent/HRP20020513A2/hr
Publication of HRP20020513B1 publication Critical patent/HRP20020513B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Spoj koji ima formului farmaceutski prihvatljive soli spomenutih spojeva, naznačen time, da je: R izabran iz skupine koja se sastoji odPatent sadrži još 8 patentnih zahtjeva.
HR20020513A 1999-12-16 2002-06-12 Substituted bisindolylmaleimides for the inhibition of cell proliferation HRP20020513B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17105199P 1999-12-16 1999-12-16
PCT/EP2000/012559 WO2001044234A1 (en) 1999-12-16 2000-12-12 Substituted bisindolylmaleimides for the inhibition of cell proliferation

Publications (2)

Publication Number Publication Date
HRP20020513A2 HRP20020513A2 (en) 2004-08-31
HRP20020513B1 true HRP20020513B1 (en) 2006-10-31

Family

ID=22622296

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020513A HRP20020513B1 (en) 1999-12-16 2002-06-12 Substituted bisindolylmaleimides for the inhibition of cell proliferation

Country Status (33)

Country Link
US (1) US6313143B1 (hr)
EP (1) EP1242408B1 (hr)
JP (2) JP2003516986A (hr)
KR (1) KR100507422B1 (hr)
CN (1) CN1229374C (hr)
AR (1) AR029415A1 (hr)
AT (1) ATE306484T1 (hr)
AU (1) AU783616B2 (hr)
BR (1) BRPI0016329B8 (hr)
CA (1) CA2392902C (hr)
CO (1) CO5050293A1 (hr)
CZ (1) CZ304130B6 (hr)
DE (1) DE60023182T2 (hr)
ES (1) ES2249314T3 (hr)
GC (1) GC0000265A (hr)
HK (1) HK1054385B (hr)
HR (1) HRP20020513B1 (hr)
HU (1) HU230003B1 (hr)
IL (2) IL150128A0 (hr)
JO (1) JO2296B1 (hr)
MA (1) MA26856A1 (hr)
MX (1) MXPA02005560A (hr)
MY (1) MY126998A (hr)
NO (1) NO322240B1 (hr)
NZ (1) NZ519173A (hr)
PE (1) PE20011034A1 (hr)
PL (1) PL200243B1 (hr)
RS (1) RS50449B (hr)
RU (1) RU2264398C2 (hr)
TW (1) TWI274752B (hr)
UY (1) UY26485A1 (hr)
WO (1) WO2001044234A1 (hr)
ZA (1) ZA200204258B (hr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002102373A1 (en) * 2001-06-15 2002-12-27 F. Hoffmann-La Roche Ag Method for administration of cancer therapeutic
EP1441772A2 (en) * 2001-10-29 2004-08-04 Nektar Therapeutics Al, Corporation Polymer conjugates of protein kinase c inhibitors
US9107911B2 (en) 2010-01-07 2015-08-18 Alkermes Pharma Ireland Limited Prodrugs of heteraromatic compounds
EP2474541A1 (en) * 2010-12-23 2012-07-11 Johannes- Gutenberg-Universität Mainz Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227850A (en) 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
GB9416467D0 (en) * 1994-08-13 1994-10-05 Wellcome Found Compounds for use in medicine
CN1304058C (zh) * 1996-03-12 2007-03-14 Pg－Txl有限公司 水溶性紫杉醇产品
TW517067B (en) * 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
PE91498A1 (es) * 1996-07-29 1998-12-22 Hoffmann La Roche Pirroles sustituidos
PE91598A1 (es) 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
PE91698A1 (es) 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
JP2002500184A (ja) * 1998-01-09 2002-01-08 アリゾナ ボード オブ リーゼンツ フェンスタチンとそのプロドラッグの合成
TR200002580T2 (tr) * 1998-03-17 2000-11-21 F.Hoffmann-La Roche Ag Hücre çoğalmasının engellenmesinde kullanılan ikameli bisindolimaleimitler
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
JP2003511449A (ja) * 1999-10-12 2003-03-25 エフ．ホフマン−ラ ロシュ アーゲー 癌の処理のための抗増殖剤としての置換されたピロール

Also Published As

Publication number Publication date
NO322240B1 (no) 2006-09-04
CZ304130B6 (cs) 2013-11-13
HU230003B1 (en) 2015-04-28
AU783616B2 (en) 2005-11-17
ES2249314T3 (es) 2006-04-01
ZA200204258B (en) 2003-08-28
MA26856A1 (fr) 2004-12-20
HRP20020513A2 (en) 2004-08-31
IL150128A (en) 2006-06-11
UY26485A1 (es) 2001-06-29
US6313143B1 (en) 2001-11-06
JP4763623B2 (ja) 2011-08-31
PL200243B1 (pl) 2008-12-31
CA2392902C (en) 2009-01-13
DE60023182D1 (de) 2006-02-23
MY126998A (en) 2006-11-30
CN1229374C (zh) 2005-11-30
WO2001044234A1 (en) 2001-06-21
JO2296B1 (en) 2005-09-12
AR029415A1 (es) 2003-06-25
EP1242408A1 (en) 2002-09-25
BR0016329A (pt) 2002-08-27
GC0000265A (en) 2006-11-01
NO20022776L (no) 2002-06-11
BRPI0016329B8 (pt) 2021-05-25
NO20022776D0 (no) 2002-06-11
ATE306484T1 (de) 2005-10-15
RU2002119209A (ru) 2004-01-10
KR100507422B1 (ko) 2005-08-10
PE20011034A1 (es) 2001-10-12
TWI274752B (en) 2007-03-01
HK1054385A1 (en) 2003-11-28
NZ519173A (en) 2004-06-25
HK1054385B (zh) 2006-02-17
RU2264398C2 (ru) 2005-11-20
EP1242408B1 (en) 2005-10-12
HUP0203696A3 (en) 2004-01-28
RS50449B (sr) 2010-03-02
CZ20022447A3 (cs) 2003-06-18
CO5050293A1 (es) 2001-06-27
HUP0203696A2 (hu) 2003-03-28
DE60023182T2 (de) 2006-07-06
AU2008201A (en) 2001-06-25
JP2007153905A (ja) 2007-06-21
KR20020063215A (ko) 2002-08-01
MXPA02005560A (es) 2002-09-02
BR0016329B1 (pt) 2013-03-19
CA2392902A1 (en) 2001-06-21
CN1409709A (zh) 2003-04-09
PL355856A1 (en) 2004-05-31
YU43302A (sh) 2005-03-15
JP2003516986A (ja) 2003-05-20
IL150128A0 (en) 2002-12-01

Similar Documents

Publication Publication Date Title
TR200100432T2 (tr) Hepatit C inhibitörü tri-peptidler
RS49688B (sr) Novi derivat 3-aril-2- hidroksipropionske kiseline (i)
HRP20000292B1 (hr) 2-fenil supstituirani imidazotriazinoni kao inhibitori fosfodiesteraze
HRP20010573B1 (hr) Triciklički inhibitori poli(adp-riboza) polimeraza
NO20030885D0 (no) Inhibitorer av <alfa>4 styrt celleadhesjon
YU48995B (sh) Derivati hinuklidina
ME00411B (me) Nova jedinjenja koja imaju inhibitorno dejstvo na transporter glukoze zavistan od natrijuma
UY26512A1 (es) Inhibidores no peptídicos de la unión celúlar dependiente de vla - 4 útiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias
TR199700419A2 (xx) Yeni piridazinon t�revleri.
YU69902A (sh) Novi derivati piperazina
MXPA02003977A (es) Inhibidores de adhesion de celula mediada por al°2.
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
WO2000004014A1 (fr) Derives de pyrimidine manifestant une activite antitumorale
MX9800804A (es) Derivados de pirrolidina que tienen actividad inhibitoria de la fosfolipasa a2.
ATE398627T1 (de) C-2-modifizierte erythromycinderivate
EP1175208A4 (en) COMPOSITION FOR PREVENTION OR TREATMENT OF DEMENTIA CONTAINING A HYDROXYCINNAMIC ACID DERIVATIVE OR AN EXTRACT OF AN ANGELICAE SPECIES CONTAINING SAID ACID
HRP20000585B1 (hr) Supstituirani bisindolmaleimidi za inhibiciju stanične proliferacije
AP9801321A0 (en) 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-h-indole derivatives.
KR20000005379A (en) Isatin derivatives as acetylcholinesterase inhibitors and analgesics
WO2000005214A3 (en) Isoquinolines as urokinase inhibitors
DE69738373D1 (de) Prenyl-transferase inhibitoren
TW354293B (en) Prodrugs of paclitaxel derivatives
HRP20000508B1 (hr) Supstituirani 2-benzilamino-2-fenil-acetamidni spojevi
BG104447A (en) Biphenylamidine derivatives
ATE229800T1 (de) Guanidino proteiase inhibitoren

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20181204

Year of fee payment: 19

ODRP Renewal fee for the maintenance of a patent

Payment date: 20191203

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20201212